Adma Biologics (ADMA) Goodwill (2017 - 2026)

Adma Biologics (ADMA) has 9 years of Goodwill data on file, last reported at $3.5 million in Q4 2025.

• Quarterly Goodwill fell 0.85% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (down 0.85% YoY) and the FY2025 annual result came in at $3.5 million, down 0.85% from the prior year.
• Goodwill held at $3.5 million in Q4 2025, from $3.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $3.5 million in Q4 2023 to a low of $3.5 million in Q3 2021.
• A 5-year average of $3.5 million and a median of $3.5 million in 2021 frame the typical range for Goodwill.
• Annual changes were most pronounced in 2023 — Goodwill increased 0.86% — and 2025, when it retreated 0.85%.
• Tracing ADMA's Goodwill over 5 years: stood at $3.5 million in 2021, then decreased by 0.84% to $3.5 million in 2022, then grew by 0.86% to $3.5 million in 2023, then changed by 0.0% to $3.5 million in 2024, then fell by 0.85% to $3.5 million in 2025.
• The last three Goodwill figures came in at $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.